REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $566 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
Q1 2023 | $31,550,538 | -2.1% | 187,399 | -1.6% | 0.52% | -13.0% |
Q4 2022 | $32,231,079 | -10.0% | 190,367 | -0.6% | 0.60% | -3.8% |
Q3 2022 | $35,830,000 | +0.5% | 191,490 | -12.8% | 0.62% | -1.7% |
Q2 2022 | $35,660,000 | -14.9% | 219,583 | -1.5% | 0.64% | +64.3% |
Q1 2022 | $41,916,000 | -64.1% | 222,850 | -49.4% | 0.39% | -41.7% |
Q4 2021 | $116,679,000 | -10.7% | 440,565 | -2.6% | 0.66% | -1.9% |
Q3 2021 | $130,663,000 | +40.5% | 452,136 | -3.0% | 0.68% | +48.1% |
Q2 2021 | $93,023,000 | +2.3% | 466,001 | -0.4% | 0.46% | -6.7% |
Q1 2021 | $90,964,000 | -1.2% | 467,899 | -2.6% | 0.49% | +7.2% |
Q4 2020 | $92,102,000 | +29.3% | 480,625 | -0.5% | 0.46% | +4.1% |
Q3 2020 | $71,255,000 | +16.5% | 482,953 | -2.4% | 0.44% | -8.4% |
Q2 2020 | $61,181,000 | +23.2% | 494,952 | -3.8% | 0.48% | -19.5% |
Q1 2020 | $49,647,000 | +0.7% | 514,266 | -3.5% | 0.60% | +16.2% |
Q4 2019 | $49,296,000 | – | 532,930 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |